Form 4: PAVmed General Counsel Receives 150,000 Restricted Shares

PAVmed Inc.'s General Counsel, Michael Adam Gordon, was granted 150,000 shares of restricted common stock with a vesting date in May 2028.

Summary

• Michael Adam Gordon, General Counsel of PAVmed Inc. (PAVM), acquired 150,000 shares of common stock.
• The transaction occurred on September 30, 2025, and represents a grant of restricted stock.
• The shares were granted under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan.
• The restricted stock has a single vesting date of May 20, 2028.
• The shares are subject to forfeiture if the requisite service period is not completed.
• Following this transaction, Michael Adam Gordon beneficially owns 150,000 shares directly.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a key executive is generally a positive signal for executive retention and alignment with long-term shareholder value, though it is a routine compensation event rather than a significant operational or financial announcement.

Positives

• The grant of restricted stock aligns the General Counsel's interests with the long-term performance and shareholder value of PAVmed Inc.
• This type of equity compensation is a standard practice for executive retention and motivation.

Risks

• The restricted stock is subject to forfeiture if the requisite service period is not completed by the vesting date of May 20, 2028.

Future Outlook

The grant of restricted stock with a future vesting date of May 20, 2028, indicates a long-term commitment and incentive structure for the General Counsel, aligning their future performance with the company's long-term goals.

Industry Context

The grant of restricted stock to an executive is a common and widely accepted practice in publicly traded companies across various industries, serving as a key component of executive compensation and retention strategies. It aims to align management's financial interests with the long-term success and shareholder value of the company.

Comparison to Industry Standards

• The filing does not contain specific financial results or project outcomes that would allow for a direct comparison to global benchmarks or specific comparable companies.

Corporate Governance

Related Party Transactions

• The grant of 150,000 shares of restricted common stock to Michael Adam Gordon, the General Counsel, constitutes a related party transaction as part of executive compensation.

Stakeholder Impact

• Shareholders: Potential for increased alignment of executive interests with long-term shareholder value, fostering stability in leadership.
• Management: Provides a long-term incentive and retention mechanism for the General Counsel.

Next Steps

• The restricted stock will vest on May 20, 2028, provided the requisite service period is completed.

Key Dates

Recommendation

This Form 4 reports a routine restricted stock grant to an executive, which is a standard component of compensation and retention strategies. It does not provide new information that would significantly alter the investment thesis for PAVmed Inc., thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

PAVmed, PAVM, Michael Adam Gordon, General Counsel, restricted stock, equity grant, Form 4, insider transaction, executive compensation, long-term incentive plan